Clinical Trial

Ototoxicity in Patients With MoM Hip Bearings

Study acronym: GODMOTHER
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to learn about ototoxicity in patients with a MoM hip arthroplasty. The main question it aims to answer is: • What is the prevalence of hearing loss in patients with high and low plasma metal concentrations.
Trial Details
NCT Number NCT06885411
Lead Sponsor Reinier Haga Orthopedisch Centrum
Collaborators: Reinier de Graaf Groep, Erasmus Medical Center, Zuyderland Medical Centre
Conditions Ototoxic Hearing Loss, Cobalt Poisoning, Chromium Causing Toxic Effect, Arthroplasty Complications
Enrollment 200 participants
Start Date 2023-02-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-20